This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) | MicrobiomeTrials
← Back to trials NCT07482176
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-03-16Est. Completion: 2027-11-15
Enrollment target: 284 participantsLocations Adverum Clinical Site 126, Phoenix, Arizona, United States Adverum Clinical Site 178, Phoenix, Arizona, United States Adverum Clinical Site 223, Phoenix, Arizona, United States Adverum Clinical Site 229, Scottsdale, Arizona, United States Adverum Clinical Site 242, Sun City, Arizona, United States Adverum Clinical Site 198, Springdale, Arkansas, United States Adverum Clinical Site 109, Bakersfield, California, United States Adverum Clinical Site 100, Beverly Hills, California, United States Adverum Clinical Site 201, Campbell, California, United States Adverum Clinical Site 172, Encino, California, United States Adverum Clinical Site 169, Fullerton, California, United States Adverum Clinical Site 224, Huntington Beach, California, United States Adverum Clinical Site 130, Poway, California, United States Adverum Clinical Site 215, Redlands, California, United States Adverum Clinical Site 140, Sacramento, California, United States Adverum Clinical Site 212, Sacramento, California, United States Other microbiome trials you might be interested in Neovascular Age-related Macular Degeneration
This study will assess corneal endothelial cells in participants with nAMD treated with PDS refilled every 24 weeks (Q24…
Mesa, United States Est. completion Sep 30, 2027
Neovascular Age-related Macular Degeneration nAMD
The aim of this trial is to demonstrate similarity in efficacy between ABP 938 8 mg and aflibercept (US) 8 mg by evaluat…
Long Beach, United States Est. completion Jul 31, 2027
Adverum Clinical Site 175, Santa Barbara, California, United States
Adverum Clinical Site 202, Torrance, California, United States
Adverum Clinical Site 189, Walnut Creek, California, United States
Adverum Clinical Site 200, Denver, Colorado, United States
Adverum Clinical Site 116, Denver, Colorado, United States
Adverum Clinical Site 165, Waterford, Connecticut, United States
Adverum Clinical Site 124, Deerfield Beach, Florida, United States
Adverum Clinical Site 184, Deerfield Beach, Florida, United States
Adverum Clinical Site 176, Fort Lauderdale, Florida, United States
Adverum Clinical Site 221, Fort Myers, Florida, United States
Adverum Clinical Site 236, Gainesville, Florida, United States
Adverum Clinical Site 214, Lakeland, Florida, United States
Adverum Clinical Site 168, Miami Springs, Florida, United States
Adverum Clinical Site 213, Orlando, Florida, United States
Adverum Clinical Site 183, South Miami, Florida, United States
Adverum Clinical Site 238, Winter Haven, Florida, United States
Adverum Clinical Site 182, Augusta, Georgia, United States
Adverum Clinical Site 207, Oak Park, Illinois, United States
Adverum Clinical Site 195, Carmel, Indiana, United States
Adverum Clinical Site 205, Carmel, Indiana, United States
Adverum Clinical Site 197, Hagerstown, Maryland, United States
Adverum Clinical Site 204, Hagerstown, Maryland, United States
Adverum Clinical Site 216, Jackson, Mississippi, United States
Adverum Clinical Site 240, Bloomfield, New Jersey, United States
Adverum Clinical Site 171, Teaneck, New Jersey, United States
Adverum Clinical Site 225, Liverpool, New York, United States
Adverum Clinical Site 196, Asheville, North Carolina, United States
Adverum Clinical Site 211, Greensboro, North Carolina, United States
Adverum Clinical Site 219, Greensboro, North Carolina, United States
Adverum Clinical Site 220, Hickory, North Carolina, United States
Adverum Clinical Site 209, Wake Forest, North Carolina, United States
Adverum Clinical Site 248, Beachwood, Ohio, United States
Adverum Clinical Site 252, Portland, Oregon, United States
Adverum Clinical Site 181, Erie, Pennsylvania, United States
Adverum Clinical Site 239, Philadelphia, Pennsylvania, United States
Adverum Clinical Site 241, Bluffton, South Carolina, United States
Adverum Clinical Site 222, Ladson, South Carolina, United States
Adverum Clinical Site 145, Arlington, Texas, United States
Adverum Clinical Site 127, Austin, Texas, United States
Adverum Clinical Site 243, Austin, Texas, United States
Adverum Clinical Site 107, Conroe, Texas, United States
Adverum Clinical Site 194, Dallas, Texas, United States
Adverum Clinical Site 162, McAllen, Texas, United States
Adverum Clinical Site 232, San Marcos, Texas, United States
Adverum Clinical Site 228, Schertz, Texas, United States
Adverum Clinical Site 231, The Woodlands, Texas, United States
Adverum Clinical Site 237, Tyler, Texas, United States
Adverum Clinical Site 199, Lynchburg, Virginia, United States
Adverum Clinical Site 249, Silverdale, Washington, United States